Clinical Trial: Phase II Trial of Anti-HER2 Treatment in HER2-enriched Early Breast Cancer Identified by PAM50 (HER2E-PAM, PAMILIA Study)

Press/Media: Press / Media

Period2021 Mar 27

Media coverage

2

Media coverage

  • TitleClinical Trial: Phase II Trial of Anti-HER2 Treatment in HER2-enriched Early Breast Cancer Identified by PAM50 (HER2E-PAM, PAMILIA Study)
    Media name/outletHealth Daily Digest (Ht Media)
    CountryIndia
    Date21/3/27
    PersonsJeong Joon
  • TitleClinical Trial: Phase II Trial of Anti-HER2 Treatment in HER2-enriched Early Breast Cancer Identified by PAM50 (HER2E-PAM, PAMILIA Study)
    Media name/outletUS Fed News
    CountryUnited States
    Date21/3/27
    PersonsJeong Joon